Related Experiment Video
Updated: Jun 5, 2026

Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization
Published on: October 24, 2025
Out of pocket expenditure incurred by couples seeking infertility services at tertiary level facilities in India
Asim Kumar Padhan1, Prerana Patil2, Akshita Vikani3
1Department of Operational Research, ICMR-National Institute For Research in Reproductive and Child Health, Mumbai, Maharashtra, India.
Abstract:
Background and objectives Diagnosis and treatment of infertility, mostly sought at tertiary facilities, contribute to substantial out-of-pocket expenditure (OOPE). This study estimated OOPE among couples seeking care for endometriosis, male infertility, polycystic ovary syndrome (PCOS), tubal factor, and uterine factor, including costs of diagnosis, management, and intrauterine insemination (IUI). Methods A cross-sectional study was conducted across five tertiary healthcare facilities (three public, two private) selected through convenience sampling to represent different regions. Based on mean (SD) OOPE INR (₹)144,393 (₹130,943), effect size 0.16, α=0.05, and 80% power, the sample was equally distributed across sites and IVF/non-IVF groups, with ∼100 participants per site. Couples were interviewed between April 2022-March 2023. Catastrophic health expenditure was defined as infertility spending exceeding 40% of annual household non-food expenditure. OOPE over the preceding year covered direct medical, non-medical, and indirect costs. Results Annual median OOPE was ₹11,317 (US $136.5) (IQR: ₹4,801-₹19,513) US $, higher in private facilities ₹14,217 ($171.4) (IQR: ₹8,030-₹21,848) than public facilities ₹8,355 ($100.7) (IQR: ₹3,785-₹17,386). Direct medical costs were the major contributor: median ₹5,802 ($69.9) (IQR: ₹2,186-₹11,847) Highest OOPE was for endometriosis ₹15,084 ($181.9) (IQR: ₹8,114-₹20,758), followed by uterine factor and male infertility ₹13,211 ($159.3) (IQR: ₹6,654-₹21,521). OOPE increased with absence of insurance (₹6,919; $83.4), comorbidities (₹2,593; $31.3), IUI (₹2,668; $32.1), and PCOS (₹2,004; $24.1). Catastrophic Health Expenditure was associated with comorbidities (OR=1.61), IUI (OR=1.88), and lower per capita income <₹59,400 ($715.7) (OR=3.44). Overall, 59.4% experienced CHE. Interpretation and conclusions Infertility care imposes substantial out of pocket expenditure in India. Strengthened insurance coverage and public sector investment are critical for equitable access.
Related Concept Videos
Infertility in Females
Endometriosis, a condition characterized by abnormal growth of endometrial...
Infertility in Males
In Vitro Fertilization
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
Tertiary Healthcare System
Oogenesis
Secondary Healthcare System

